Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Potential Beneficial Effects of Marine Peptide on Human Neuron Health.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
Structural brain lesions in inflammatory bowel disease.
Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
Seizure characteristics in multiple sclerosis patients.
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases.
Vitamin D immunomodulatory potential in multiple sclerosis.
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.
Voice-related quality of life in patients with multiple sclerosis.
Mimics and rare presentations of pediatric demyelination.
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Alexithymia in Neurological Disease: A Review.
Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
Pain and spinal cord imaging measures in children with demyelinating disease.
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.
Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.
Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.

Pages